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2-Pyrazolines 7-12 bearing a carboxylic acid ester or a carboxamide side-chain have been 
prepared by treatment of the appropriate chalcone derivatives 2-6 with hydrazine hydrate or 
phenylhydrazine in hot acetic acid. 1-(2-Carboxyphenyl)-2-pyrazolines 24-30 and 1-(4-
carboxyphenyl)-2-pyrazolines 31-41 were synthesized by the reaction of chalcones with (2-
carboxyphenyl)hydrazine and (4-carboxyphenyl)hydrazine in hot acetic acid. Structures of all 
new compounds have been elucidated by microanalyses, 1H-, 13C-NMR and IR spectroscopic 
measurements.   
 






Pyrazolines are well known nitrogen-containing heterocyclic compounds and several procedures 
have been developed for their synthesis.1-3 Numerous pyrazolines have been found to possess 
important bioactivities, viz. central nervous system,4 antimicrobial and antimycotic,5,6 
immunosuppressive,7 etc. activities. As far as the different pyrazoline isomers are concerned, 2-
pyrazoline derivatives became the most frequently studied pyrazolines. Various methods are 
used for the preparation of 2-pyrazolines. Treatment of α,β-unsaturated aldehydes and ketones 
with hydrazines seems to be the most popular procedure for this purpose. This reaction has been 
conducted under various conditions.8-42 As a hydrazine reagent, hydrazine hydrate or 
phenylhydrazine were used almost in all cases. Utilization of p-sulfamylphenylhydrazine is 
mentioned to prepare N-(p-sulfamylphenyl)-2-pyrazolines only in few cases.43,44 In our previous 
paper,40 use of (2-carboxyphenyl)hydrazine and (4-carboxypehnyl)hydrazine has been described 
for the synthesis of carboxylated styryl-2-pyrazolines.   
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 As mentioned, 2-pyrazolines possess valuable bioactivities which stimulated the preparation 
of their numerous derivatives. Insertion of carboxy, carboxamide or carboxylic acid ester group 
into 2-pyrazoline molecules may be beneficial to their bioactivities. Taking this expected effect 




Results and Discussion 
 
One of the aims of our present study was to synthesize new 2-pyrazolines with a carboxylic acid 
type side-chain. The planned side-chain was introduced into the chalcone molecules used as 
starting materials. For this purpose, 4’-hydroxychalcone (1) was allowed to react with the 
appropriate chloroacetic acid derivative in hot anhydrous acetone in the presence of potassium 
carbonate to afford chalcones 2-6 (Scheme 1). Previously, acetic acid was found to be a 
convenient and cheap solvent for the synthesis of a wide variety of 2-pyrazolines by the reaction 
of α,β-unsaturated ketones and hydrazines.9,33-42 For this reason, chalcones 2-6 were allowed to 
react either with hydrazine hydrate or with phenylhydrazine to obtain 2-pyrazolines 7-12 
(Scheme 1) in good (62-89%) yields. These new 1-substituted 2-pyrazolines bear either a 



























2,7: R1 = MeO,  R2 = MeCO
3,8: R1 = EtO,  R2 = MeCO
4,9: R1 = NH2,  R2 = MeCO
5,10: R1 =                ,  R2 = MeCONH
5,11: R1 =                 ,  R2 =NH
























 In case chalcones 13, 16-18 and 20-22 were treated with (2-carboxyphenyl)hydrazine in hot 
acetic acid 1-(2-carboxyphenyl)-2-pyrazolines 24-30 (Scheme 2) were prepared in medium to 
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good (58-65%) yields. This is  the first example for the reaction of chalcones with (2-















13,24: R1 = R2 = R4 = H, R3 = COOH
16,25: R1 = F, R2 = R4 = H, R3 = COOH
17,26: R1 = Cl, R2 = R4 = H, R3 = COOH




20,28: R1 = R4 = H, R2 = Me, R3 = COOH
21,29: R1 = R4 = H, R2 = Cl, R3 = COOH
22,30: R1 = R4 = H, R2 = Br, R3 = COOH
13,31: R1 = R2 = R3 = H, R4 = COOH
14,32: R1 = Me, R2 = R3 = H, R4 = COOH
15,33: R1 = MeO, R2 = R3 = H, R4 = COOH
16,34: R1 = F, R2 = R3 = H, R4 = COOH
17,35: R1 = Cl, R2 = R3 = H, R4 = COOH
18,36: R1 = Br, R2 = R3 = H, R4 = COOH
19,37: R1 = NO2, R2 = R3 = H, R4 = COOH
20,38: R1 = R3 = H, R2 = Me, R4 = COOH
21,39: R1 = R3 = H, R2 = Cl, R4 = COOH
22,40: R1 = R3 = H, R2 = Br, R4 = COOH




 Chalcones 13-23 were allowed to react with (4-carboxyphenyl)hydrazine in boiling acetic 
acid and 1-(4-carboxyphenyl)-2-pyrazolines 31-41 (Scheme 2) were obtained in 
medium to good (57-84%) yields. Our experimental results unequivocally prove that both the (2-
carboxyphenyl)hydrazine and the (4-carboxyphenyl)hydrazine are convenient hydrazine 
derivatives for the synthesis of carboxylated 2-pyrazolines.  
 Structures of all new compounds have been elucidated by microanalyses, IR and NMR 
spectroscopic measurements. Elemental analyses unambiguously proved the elemental 
composition of all new compounds. In their IR spectra a characteristic C=N band was assigned 
between 1594 and 1605 cm-1 referring to a C=N double bond between the N-2 and  C-3 atoms. In 
the 1H-NMR spectra of 2-pyrazolines 7-12 and 24-41  the three hydrogen atoms attached to the 
C-4 and C-5 carbon atoms of the heterocyclic ring gave an ABX spin system. Measured 
chemical shift and coupling constant values (cf. Experimental Section) unequivocally prove the 
2-pyrazoline structure. Owing to a strong hydrogen bond, in the case of the 1-(2-carboxyphenyl)-
2-pyrazolines 24-30 no proton signal belonging to a carboxyl group could be detected. However, 
in the 1H-NMR spectra of 1-(4-carboxyphenyl)-2-pyrazolines 31-41 a distinct singlet signal 
assigned to the carboxyl group was found around 12.10-12.40 ppm. 13C-NMR chemical shift 
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values of carbon atoms C-3 (146-150 ppm), C-4 (43-44 ppm) and   C-5 (62-64 ppm) corroborate 
the 2-pyrazoline structure deduced from the 1H-NMR spectroscopic data. 
 In conclusion, we have synthesized hitherto unknown carboxylic acid derivatives of  2-
pyrazolines which may serve as beneficial substances for drug research. Our experimental results 
prove that (2-carboxyphenyl)hydrazine and (4-carboxyphenyl)hydrazine are convenient reagents 
for the synthesis of 2-pyrazolines by treatment of α,β-unsaturated ketones with hydrazines.      
 
 
Experimental Section  
 
General Procedures. Melting points were determined on a Kofler hot-stage apparatus and are 
uncorrected. 1H- and 13C-NMR spectra were measured with a Bruker WP 200 SY spectrometer 
at 200/50 MHz in CDCl3 or DMSO-d6 (internal standard TMS, δ = 0.0 ppm) at ambient 
temperature (ca 20 oC). The IR spectra were obtained in KBr discs with a Perkin-Elmer 16 PC 
instrument. Elemental analyses (C, H, N) were measured in-house with a Carlo Erba 1106 EA 
instrument. TLC was performed on Kieselgel 60 F254 (Merck) layer using toluene: ethyl acetate 
(4:1 v/v) or 1,2-dichloroethane as eluents. Starting materials 1 and 13-23 were synthesized 
according to known procedures.45-50 
 
General procedure for the preparation of chalcone derivatives 2-6 
A mixture of 4’-hydroxychalcone (1, 20.0 mmoles), the appropriate chloroacetic acid derivative 
(25.0 mmoles), potassium carbonate (5.0 g) and anhydrous acetone (200 mL) was refluxed for 6 
h, then the inorganic salts were separated by filtration and the solvent was evaporated under 
reduced pressure. The residue was crystallized from methanol to obtain compounds 13-17 
(Scheme 1).  
 
4’-(Methoxycarbonyl)methoxychalcone (2). Prepared as white needles in 81% yield, mp 109-
110 oC; 1H-NMR (δ,CDCl3): 3.82 (3H, s, Me), 4.73 (2H, s, CH2), 7.02-8.06 (m, 9 arom. H + Hα 
+ Hβ); 13C-NMR (δ, CDCl3): 52.3, 65.1, 114.4, 121.8, 128.3, 128.9, 130.3, 130.8, 132.1, 134.9, 
144.2, 161.4, 168.7, 188.7; IR (cm-1: 1758, 1655, 1604, 1448, 1338, 1218, 1177, 1085, 1021, 
988, 837, 766, 567; Anal. Calcd. for C18H16O4: C, 72.96; H, 5.44. Found: C, 72.87; H, 5.49. 
4’-(Ethoxycarbonyl)methoxychalcone (3). Obtained as white plates in 78% yield, mp 76-77 
oC; 1H-NMR (δ, CDCl3): 1.34 (3H, t, J = 7.4 Hz, CH2CH3), 4.31 (2H, q, J = 7.4 Hz, CH2CH3), 
4.73 (2H, s, CH2), 6.98-8.08 (m, 9 arom. H + Hα + Hβ); 13C-NMR (δ, CDCl3): 14.1, 61.5, 65.2, 
114.4, 121.8, 128.3, 128.9, 130.3, 130.7, 132.0, 134.9, 144.2, 161.4, 168.2, 188.6;            IR (cm-
1): 1763, 1657, 1604, 1448, 1419, 1340, 1206, 1182, 1088, 1037, 976, 831, 766, 697; Anal. 
Calcd. for C19H18O4: C, 73.53; H, 5.84. Found: C, 73.62; H, 5.78. 
4’-(Aminocarbonyl)methoxychalcone (4). Isolated as white plates in 74% yield, mp 191-192 
oC; 1H-NMR (δ, CDCl3): 4.61 (2H, s, CH2), 7.08-8.22 (m, 9 arom. H + Hα + Hβ) 8.41 (2H, s, 
NH2); 13C-NMR (δ, CDCl3): 66.6, 114.6, 121.9, 128.7, 128.8, 130.3, 130.7, 134.7, 143.1, 161.6, 
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169.3, 187.4; IR (cm-1): 3478, 3143, 1693, 1659, 1607, 1509, 1419, 1341, 1303, 1256, 1219, 
1176, 1058, 1034, 832, 765, 690; Anal. Calcd. for C17H15NO3: C, 72.58; H, 5.37; N, 4.98. Found: 
C, 72.66; H, 5.32; N, 5.05. 
4’-(Phenylaminocarbonyl)methoxychalcone (5). Obtained as pale yellow needles in 83% 
yield, mp 160-161 oC; 1H-NMR (δ, CDCl3): 4.69 (2H, s, CH2), 7.08-8.21 (m, 14 arom. H + Hα + 
Hβ), 8.27 (1H, s, NH); 13C-NMR (δ, CDCl3): 67.4, 114.7, 120.2, 121.6, 125.1, 128.4, 128.9, 
129.1, 130.5, 131.0, 132.7, 134.9, 136.6, 160.4, 165.4, 188.6; IR (cm-1): 3405, 3058, 1686, 1655, 
1603, 1534, 1500, 1446, 1341, 1308, 1244, 1224, 1190, 1061, 1034, 829, 766, 690; Anal. Calcd. 
for C23H19NO3: C, 77.29; H, 5.36; N, 3.92. Found: C, 77.21; H, 5.41; N, 3.96. 
4’-[(2-Ethyl-6-methylphenylamino)carbonyl]methoxychalcone (6). Prepared as pale yellow 
plates in 81% yield, mp 171-172 oC; 1H-NMR (δ, CDCl3): 1.17 (3H, t, J = 7.8 Hz, CH2CH3), 
2.26 (3H, s, Me), 2.53 (2H, q, J = 7.8 Hz, CH2CH3), 4.79 (2H, s, CH2), 7.10 -8.11 (m, 12 arom. 
H + Hα + Hβ), 8.30 (1H, s, NH); 13C-NMR (δ, CDCl3): 14.5, 18.4, 24.9, 67.5, 114.6, 121.6. 
126.5, 128.1, 128.4, 128.9, 130.5, 131.0, 131.8, 132.6, 134.9, 135.9, 141.0, 144.6, 160.6, 166.2, 
188.5; IR (cm-1): 3195, 3047, 1661, 1606, 1508, 1448, 1339, 1303, 1219, 1172, 1034, 981, 837, 
765, 695ł; Anal. Calcd. for C26H25NO3: C, 78.17; H, 6.31; N, 3.50. Found: C, 78.26; H, 6.26; N, 
3.45. 
 
General procedure for the synthesis of ester and carboxamide derivatives of 2-pyrazolines 
7-12 
A mixture of chalcone derivative (2-6, 5.0 mmoles), hydrazine hydrate (25.0 mmoles) or 
phenylhydraziene (25.0 mmoles) and acetic acid (30 mL) was heated at reflux for 4 h, then 
poured onto crushed ice. The precipitate was separated by filtration, washed with water, and 
crystallized from methanol to obtain 2-pyrazolines 7-12 (Scheme 1).  
 
1-Acetyl-3-[4-(methoxycarbonyl-methoxy)phenyl]-5-phenyl-2-pyrazoline (7). Isolated as 
white needles in 65% yield, mp 141-142 oC; 1H-NMR (δ, CDCl3): 2.42 (3H, s, Me), 3.11 (1H, 
dd, J = 4.3, 17.6 Hz, 4-Htrans), 3.72 (1H, dd, J = 12.1, 17.6 Hz, 4-Hcis), 3.84 (3H, s, Me), 4.70 
(2H, s, CH2), 5.58 (1H, dd, J = 4.3, 12.1 Hz, 5-H), 6.92-7.71 (m. 9 arom. H); 13C-NMR (δ, 
CDCl3): 21.8, 42.3, 52.3, 59.8, 65.1, 114.8, 125.2, 125.5, 127.6, 128.2, 128.8, 141.8, 153.3, 
159.3, 168.8; IR (cm-1): 1670, 1605, 1548, 1517, 1445, 1326, 1251, 1178, 1058, 836, 759, 696; 
Anal. Calcd. for C20H20N2O4: C, 68.17; H, 5.72; N, 7.95. Found: C, 68.26; H, 5.77; N, 7.87. 
1-Acetyl-3-[4-(ethoxycarbonyl-methoxy)phenyl]-5-phenyl-2-pyrazoline (8). Prepared as 
white needles in 72% yield, mp 127-128 oC; 1H-NMR (δ, CDCl3): 1.30 (3H, t, J = 6.8 Hz, 
CH2CH3), 2.43 (3H, s, Me), 3.11 (1H, dd, J = 4.8, 17.5 Hz, 4-Htrans), 3.70 (1H, dd, J = 11.7, 17.5 
Hz, 4-Hcis), 4.26 (2H, q, J = 6.8 Hz, CH2CH3), 4.68 (2H, s, CH2), 5.59 (1H, dd, J = 4.8, 11.7 Hz, 
5-H), 6.94-7.69 (m, 9 arom. H); 13C-NMR (δ, CDCl3): 14.0, 21.8, 42.3, 59.8, 65.2, 114.8, 125.1, 
125.5, 127.5, 128.2, 128.8, 141.8, 153.3, 159.4, 168.6; IR (cm-1): 1655, 1599, 1537, 1444, 1410, 
1321, 1257, 1206, 1062, 960, 862, 756, 700; Anal. Calcd. for C21H22N2O4: C, 68.84; H, 6.05; N, 
7.64. Found: 68.93; H, 6.11; N, 7.56. 
General Papers                                                                                                                 ARKIVOC 2007 (i) 134-145 
ISSN 1424-6376                                                       Page 139                                                       ©ARKAT USA, Inc. 
1-Acetyl-3-[4-(aminocarbonyl-methoxy)phenly]-5-phenyl-2-pyrazoline (9). Obtained as 
white plates in 62% yield, mp 163-164 oC; 1H-NMR (δ, DMSO-d6): 2.30 (3H, s, Me), 3.09 (1H, 
dd, J = 4.3, 17.9 Hz, 4-Htrans), 3.84 (1H, dd, J = 11.6, 17.9 Hz, 4-Hcis), 4.67 (2H, s, CH2), 5.52 
(1H, dd, J = 4.3, 11.6 Hz, 5-H), 7.02-7.73 (m, 9 arom H), 9.82 (2H, s, NH2); 13C-NMR (δ, 
DMSO-d6): 20.3, 21.5, 59.2, 65.8, 114.9, 124.4, 125.3, 127.0, 128.1, 128.5, 142.4, 153.7, 159.2, 
166.1, 167.9; IR (cm-1): 3481, 3144, 1694, 1656, 1597, 1534, 1441, 1416, 1321, 1248, 1210, 964, 
963, 760, 702; Anal. Calcd. for C19H19N3O3: C, 67.64; H, 5.68; N, 12.45. Found: C, 67.72; H, 
5.63; N, 12.52. 
1-Acetyl-3-[4-(phenylaminocarbonyl-methoxy)phenyl]-5-phenyl-2-pyrazoline (10). Prepared 
as pale yellow plates in 73%, mp 205-206 oC; 1H-NMR (δ, CDCl3): 2.46 (3H, s, Me), 3.08 (1H, 
dd, J = 7.4, 17.2 Hz, 4-Htrans), 3.78 (1H, dd, J = 12.2, 17.2 Hz, 4-Hcis), 4.61 (2H, s, CH2), 5.21 
(1H, dd, J = 7.4, 12.2 Hz, 5-H), 6.74-7.69 (m, 14 arom. H), 8.21 (1H, s, NH); 13C-NMR (δ, 
CDCl3): 21.9, 42.3, 59.9, 67.6, 115.0, 120.1, 125.0, 125.5, 125.9, 127.6, 128.5, 128.9, 129.1, 
136.6, 141.8, 153.0, 158.4, 165.6, 168.7; IR (cm-1): 1673, 1598, 1536, 1498, 1445, 1389, 1321, 
1243, 1175, 1120, 1069, 872, 830, 748, 699; Anal. Calcd. for C25H23N3O3: C, 72.62; H, 5.61; N, 
10.16. Found: C, 72.71; H, 5.67; N, 10.07. 
1,5-Diphenyl-3-[4-(phenylaminocarbonyl-methoxy)phenyl]-2-pyrazoline (11). Obtained as 
pale yellow needles in 71% yield, mp 212-213 oC; 1H-NMR (δ, CDCl3): 3.09 (1H, dd, J = 7.3, 
17.4 Hz, 4-Htrans), 3.81 (1H, dd, J = 12.0, 17.4 Hz, 4-Hcis), 4.62 (2H, s, CH2), 5.24 (1H, dd, J = 
7.3, 12.0 Hz, 5-H), 6.70-7.81 (m, 19 arom. H), 8.24 (1H, s, NH); 13C-NMR (δ, CDCl3): 43.4, 
64.6, 67.6, 111.7, 112.5, 113.4, 114.9, 119.4, 124.8, 124.9, 125.5, 125.8, 127.6, 128.5, 128.7, 
129.1, 130.0, 134.7, 136.8, 142.3, 144.5, 145.8, 157.1, 166.0; IR (cm-1): 1678, 1598, 1536, 1498, 
1445, 1321, 1243, 1175, 1120, 1069, 872, 830, 748, 699; Anal. Calcd. for C29H25N3O2: C, 77.83, 
H, 5.63; N, 9.38. Found: 77.74; H, 5.69; N, 9.46. 
1,5-Diphenyl-3-[4-(2-ethyl-6-methylphenylamino-carbonyl-methoxy)phenyl]-2-pyrazol-ine 
(12). Isolated as white plates in 89% yield, mp 195-196 oC; 1H-NMR (δ, CDCl3): 1.16 (3H, t, J = 
7.4 Hz, CH2CH3), 2.23 (3H, s, Me), 2.56 (2H, q, J = 7.4, CH2CH3), 3.12 (1H, dd, J = 7.4, 17.2 
Hz, 4-Htrans), 3.83 (1H, dd, J = 12.4, 17.2 Hz, 4-Hcis), 4.73 (2H, s, CH2), 5.26 (1H, dd, J = 7.4, 
12.4 Hz, 5-H), 6.77-7.74 (m, 17 arom. H), 7.83 (1H, s, NH); 13C-NMR (δ, CDCl3): 14.5, 18.5, 
24.8, 67.6, 114.6, 114.8, 125.3, 126.5, 127.5, 128.4, 128.7, 128.9, 129.1, 130.4, 135.9, 139.8, 
141.1, 144.6, 151.1, 157.1, 166.9; IR (cm-1): 1668, 1597, 1498, 1391, 1245, 1177, 1125, 1069, 
873, 832, 748, 700; Anal. Calcd. for C32H31N3O3: C, 78.50; H, 6.38; N, 8.58. Found: C, 78.60; H, 
6.32; N, 8.48. 
 
General procedure for the preparation of 1-(2-carboxyphenyl)-2-pyrazolines 24-30 
A mixture of the appropriate chalcone (13,16-18,20-22, 10.0 mmoles), (2-carboxyphenyl)-
hydrazine (30.0 mmoles) and acetic acid (60 mL) was refluxed for 5 h, then poured onto crushed 
ice. The oily precipitate was extracted with chloroform. This solution was washed with brine, 
dried with CaCl2 and the solvent was evaporated under reduced pressure. The residue was 
crystallized from methanol to obtain 1-(2-carboxyphenyl)-2-pyrazolines 24-30 (Scheme 2). 
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1-(2-Carboxyphenyl)-3,5-diphenyl-2-pyrazoline (24). Prepared as white needles in 61% yield, 
mp 140-141 oC; 1H-NMR (δ, CDCl3): 3.12 (1H, dd, J = 7.1, 17.2 Hz, 4-Htrans), 3.81 (1H, dd, J = 
12.3, 17.2 Hz, 4-Hcis), 5.27 (1H, dd, J = 7.1, 12.3 Hz, 5-H), 6.78-7.73 (m, 14 arom. H); 13C-NMR 
(δ, CDCl3): 43.5, 64.4, 113.4, 119.1, 125.7, 125.8, 127.5, 128.5, 128.9, 129.1, 132.7, 142.9, 
144.9, 146.7; IR (cm-1): 1597, 1503, 1455, 1394, 1325, 1267, 1125, 1070, 1030, 873, 759, 692; 
Anal. Calcd. for C22H18N2O2: C, 77.l7; H, 5.30; N, 8.18. Found: C, 77.08; H, 5.36; N, 8.11. 
1-(2-Carboxyphenyl)-3-(4-fluorophenyl)-5-phenyl-2-pyrazoline (25). Obtained as pale yellow 
needles in 59% yield, mp 136-137 oC; 1H-NMR (δ, CDCl3): 3.07 (1H, dd, J = 7.3, 16.8 Hz, 4-
Htrans), 3.80 (1H, dd, J = 12.3, 16.8 Hz, 4-Hcis), 5.22 (1H, dd, J = 7.3, 12.3 Hz, 5-H), 6.75-7.69 
(m, 13 arom. H); 13H-NMR (δ, CDCl3): 43.6, 64.6, 113.3, 115.3, 115.8, 119.1, 125.3, 125.8, 
126.7, 127.6, 128.5, 128.9, 129.1, 142.5, 144.8, 145.8; IR (cm-1): 1598, 1500, 1390, 1326, 1228, 
1130, 1070, 874, 835, 745, 699; Anal. Calcd. for C22H17FN2O2: C, 73.32; H, 4.76; N, 7.77. 
Found: 73.40; H, 4.81; N, 7.69. 
1-(2-Carboxyphenyl)-3-(4-chlorophenyl)-5-phenyl-2-pyrazoline (26). Isolated as yellow 
plates in 65% yield, mp 128-129 oC; 1H-NMR (δ, CDCl3): 3.08 (1H, dd, J = 7.3, 16.8 Hz,     4-
Htrans), 3.77 (1H, dd, J = 12.4, 16.8 Hz, 4-Hcis), 5.24 (1H, dd, J = 7.3, 12.4 Hz, 5-H), 6.78-7.62 
(m, 13 arom. H); 13C-NMR (δ, CDCl3): 43.3, 64.6, 113.4, 119.3, 125.8, 126.8, 127.6, 128.5, 
128.7, 128.9, 129.2, 129.9, 130.7, 131.3, 134.2, 142.3, 144.6, 145.5; IR (cm-1): 1598, 1502, 1322, 
1245, 1129, 1089, 1011, 869, 826, 745, 701, Anal. Calcd. for C22H17Cl N2O2: C, 70.12; H, 4.55; 
N, 7.43. Found: C, 70.04; H, 4.61; N, 7.49. 
3-(4-Bromophenyl)-1-(2-carboxyphenyl)-5-phenyl-2-pyrazoline (27). Obtained as pale yellow 
plates in 61% yield, mp 151-152 oC; 1H-NMR (δ, CDCl3): 3.08 (1H, dd, J = 7.4, 17.1 Hz, 4-
Htrans), 3.79 (1H, dd, J = 12.4, 17.1 Hz, 4-Hcis), 5.77 (1H, dd, J = 7.4, 12.4 Hz, 5-H), 6.79-7.78 
(m, 13 arom. H); 13C-NMR (δ, CDCl3): 43.3, 64.6, 113.4, 119.3, 125.3, 125.8, 127.1, 127.4, 
127.6, 128.5, 128.7, 128.9, 129.2, 131.6, 131.7, 142.3, 144.5, 145.5; IR (cm-1): 1597, 1545, 1501, 
1324, 1243, 1133, 1072, 1008, 871, 822, 744, 693; Anal. Calcd. for C22H17BrN2O2: C, 62.72; H, 
4.07; N, 6.65. Found: C, 62.64; H, 4.11; N, 6.57. 
1-(2-Carboxyphenyl)-5-(4-methylphenyl)-3-phenyl-2-pyrazoline (28). Prepared as white 
needles in 60% yield, mp 133-134 oC; 1H-NMR (δ, CDCl3): 2.60 (3H, s, Me), 3.08 (1H, dd, J = 
7.4, 17.3 Hz, 4-Htrans), 3.76 (1H, dd, J = 11.9, 17.3 Hz, 4-Hcis), 5.21 (1H, dd, J = 7.4, 11.9 Hz, 5-
H), 6.72-7.74 (m, 13 arom. H); 13C-NMR (δ, CDCl3): 21.0, 43.5, 64.2, 113.3, 118.9, 125.7, 
125.8, 128.5, 128.8, 129.7, 132.8, 137.2, 139.6, 144.9, 146.7; IR (cm-1): 1597, 1503, 1460, 1447, 
1392, 1334, 1271, 1124, 1069, 1001, 869, 810, 756, 688; Anal. Calcd. for C23H20N2O2: C, 77.15; 
H, 5.65; N, 7.86. Found: C, 77.61; H, 5.69; N, 7.78. 
1-(2-Carboxyphenyl)-5-(4-chlorophenyl)-3-phenyl-2-pyrazoline (29). Isolated as pale yellow 
plates in 58% yield, mp 131-132 oC; 1H-NMR (δ, CDCl3): 3.08 (1H, dd, J = 7.3, 17.2 Hz, 4-
Htrans), 3.82 (1H, dd, J = 12.4, 17.2 Hz, 4-Hcis), 5.23 (1H, dd. J = 7.3, 12.4 Hz, 5-H), 6.80-7.74 
(m, 13 arom. H); 13C-NMR (δ, CDCl3): 43.4, 63.8, 113.4, 119.3, 125.7, 128.5, 128.7, 128.9, 
133.3, 141.0, 144.6, 146.7; IR (cm-1): 1594, 1493, 1455, 1392, 1319, 1240, 1127, 1090, 1068, 
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1014, 869, 823, 754, 689; Anal. Calcd. for C22H17ClN2O2: C, 70.12; H, 4.55; N, 7.43. Found: C, 
70.19; H, 4.50; N, 7.36. 
5-(4-Bromophenyl)-1-(2-carboxyphenyl)-3-phenyl-2-pyrazoline (30). Prepared as yellow 
plates in 64% yield, mp 134-135 oC; 1H-NMR (δ, CDCl3): 3.09 (1H, dd, J = 7.3, 17.3 Hz,   4-
Htrans), 3.81 (1H, dd, J = 12.8, 17.3 Hz, 4-Hcis), 5.23 (1H, dd, J = 7.3, 12.4 Hz, 5-H), 6.80-7.73 
(m, 13 arom. H); 13C-NMR (δ, CDCl3): 43.3, 63.8, 113.3, 119.3, 121.3, 125.7, 127.6, 128.5, 
128.7, 128.9, 132.3, 132.5, 141.6, 144.6, 146.7; IR (cm-1): 1596, 1502, 1447, 1393, 1334, 1128, 
1070, 1011, 869, 821, 753, 689; Anal. Calcd. for C22H17BrN2O2: C, 62.72; H, 4.07; N, 6.65. 
Found: C, 62.81; H, 4.01; N, 6.72.  
 
General procedure for the synthesis of 1-(4-carboxyphenyl)-2-pyrazolines 31-41 
A mixture of chalcone (13-23, 10.0 mmoles), (4-carboxyphenyl)hydrazine (30.0 mmoles) and 
acetic acid (50 mL) was heated at reflux for 7 h, then pured onto crushed ice. The precipitate was 
separated by filtration, washed with water and crystallized from methanol to afford 1-(4-
carboxyphenyl)-2-pyrazolines 31-41 (Scheme 2).  
 
1-(4-Carboxyphenyl)-3,5-diphenyl-2-pyrazoline (31). Isolated as white needles in 61% yield, 
mp 242-243 oC; 1H-NMR (δ, DMSO-d6): 3.20 (1H, dd, J = 5.2, 17.9 Hz, 4-Htrans), 3.89 (1H, dd, J 
= 12.1, 17.9 Hz, 4-Hcis), 5.63 (1H, dd, J = 5.2, 12.1 Hz, 5-H), 7.04-7.91 (m, 14 arom. H), 12.29 
(1H, s, COOH); 13C-NMR (δ, DMSO-d6): 42.9, 62.3, 111.8, 119.8, 125.2, 125.9, 127.4, 128.6, 
129.1, 130.7, 131.6, 141.7, 149.5, 167.1; IR (cm-1): 1671, 1598, 1522, 1405, 1326, 1281, 1174, 
1131, 1095, 868, 770, 696; Anal. Calcd. for C22H18N2O2: C, 77.17; H, 5.30; N, 8.18. Found: C, 
77.27; H, 5.26; N, 8.26. 
1-(4-Carboxyphenyl)-3-(4-methylphenyl)-5-phenyl-2-pyrazoline (32). Prepared as yellow 
needles in 72% yield, mp 258-259 oC; 1H-NMR (δ, DMSO-d6): 2.38 (3H, s, Me), 3.09 (1H, dd, J 
= 4.7, 17.4 Hz, 4-Htrans), 3.88 (1H, dd, J = 12.0, 17.4 Hz, 4-Hcis), 5.59 (1H, dd, J = 4.7, 12.0 Hz, 
5-H), 7.01-7.78 (m, 13 arom. H), 12.24 (1H, s, COOH); 13C-NMR (δ, DMSO-d6): 20.8, 42.9, 
62.2, 111.7, 119.6, 125.5, 125.9, 127.4, 128.9, 129.2, 130.7, 138.9, 141.7, 146.9, 149.6, 167.0; 
IR (cm-1): 1672, 1599, 1512, 1395, 1282, 1174, 1127, 1094, 867, 843, 816, 771, 697; Anal. 
Calcd. for C23H20N2O2: C, 77.51; H, 5.65; N, 7.86. Found: 77.43; H, 5.71; N, 7.92. 
1-(4-Carboxyphenyl)-3-(4-methoxyphenyl)-5-phenyl-2-pyrazoline (33). Prepared as white 
needles in 57% yield, mp 265-266 oC; 1H-NMR (δ, DMSO-d6): 3.0.8 (1H, dd, J = 5.3, 17.9 Hz, 
4-Htrans), 3.80 (3H, s, MeO), 3.97 (1H, dd, J = 11.9, 17.9 Hz, 4-Hcis), 5.60 (1H, dd, J = 5.3, 11.9 
Hz, 5-H), 6.98-7.78 (m, 13 arom. H), 12.24 (1H, s, COOH); 13C-NMR (δ, DMSO-d6): 43.1, 52.5, 
62.1, 111.6, 114.1, 119.4, 124.2, 125.5, 127.4, 127.6, 128.9, 130.7, 141.8, 147.0, 149.5, 160.1, 
167.1; IR (cm-1): 1671, 1598, 1511, 1393, 1280, 1252, 1170, 1127, 1094, 842, 770, 695; Anal. 
Calcd. for C23H20N2O3: C, 74.18; H, 5.41; N, 7.52. Found: C, 74.26; H, 5.36; N, 7.59. 
1-(4-Carboxyphenyl)-3-(4-fluorophenyl)-5-phenyl-2-pyrazoline (34). Obtained as pale yellow 
plates in 76% yield, mp 234-235 oC; 1H-NMR (δ, DMSO-d6): 3.18 (1H, dd, J = 5.2, 17.4 Hz, 4-
Htrans), 3.97 (1H, dd, J = 12.1, 17.4 Hz, 4-Hcis), 5.62 (1H, dd, J = 5.2, 12.1 Hz,      5-H), 7.01-7.86 
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(m, 13 arom. H), 12.36 (1H, s, COOH); 13C-NMR (δ, DMSO-d6): 42.9, 62.3, 111.8, 115.3, 
115.8, 119.8, 125.5, 127.4, 128.0, 128.3, 128.9, 130.6, 141.6, 146.8, 148.6, 166.9; IR (cm-1): 
1672, 1602, 1509, 1397, 1286, 1228, 1175, 1133, 1096, 872, 838, 770, 699; Anal. Calcd. for 
C22H17FN2O2: C, 73.32; H, 4.75; N, 7.77. Found: C, 73.41; H, 4.71; N, 7.85. 
1-(4-Carboxyphenyl)-3-(3-chlorophenyl)-5-phenyl-2-pyrazoline (35). Isolated as yellow 
needles in 68% yield, mp 286-287 oC; 1H-NMR (δ, DMSO-d6): 3.19 (1H, dd, J = 5.1, 17.8 Hz, 4-
Htrans), 3.97 (1H, dd, J = 12.0, 17.8 Hz, 4-Hcis), 5.64 (1H, dd, J = 5.1, 12.0 Hz, 5-H), 7.04-7.80 
(m, 13 arom. H), 12.36 (1H, s, COOH); 13C-NMR (δ, DMSO-d6): 42.7, 62.5, 111.9, 120.1, 
125.6, 127.6, 128.6, 128.9, 130.6, 130.7, 133.6, 141.6, 146.7, 148.5, 167.0; IR (cm-1): 1667, 
1600, 1517, 1410, 1387, 1280, 1174, 1127, 1089, 871, 844, 758, 698; Anal. Calcd. for 
C22H17ClN2O2: C, 70.12; H, 4.55; N, 7.43. Found: C, 70.04; H, 4.60; N, 7.36. 
3-(4-Bromophenyl)-1-(4-carboxyphenyl)-5-phenyl-2-pyrazoline (36). Prepared as white plates 
in 61% yield, mp 293-294 oC; 1H-NMR (δ, DMSO-d6): 3.18 (1H, dd, J = 5.5, 18.0 Hz, 4-Htrans), 
3.96 (1H, dd, J = 12.0, 18.0 Hz, 4-Hcis), 5.66 (1H, dd, J = 5.5, 12.0 Hz, 5-H), 7.06-7.78 (m, 13 
arom. H), 12.36 (1H, s, COOH); 13C-NMR (δ, DMSO-d6): 42.6, 62.4, 111.9, 120.1, 122.2, 125.5, 
127.5, 127.8, 128.9, 130.6, 131.5, 141.5, 146.6, 148.5, 166.9; IR (cm-1): 1668, 1599, 1516, 1409, 
1385, 1282, 1174, 1128, 1007, 770, 698; Anal. Calcd. for C22H17BrN2O2: C, 62.72; H, 4.07; N, 
6.65. Found: C, 62.64; H, 4.03; N, 6.59. 
1-(4-Carboxyphenyl)-3-(4-nitrophenyl)-5-phenyl-2-pyrazoline (37). Obtained as yellow 
plates in 68% yield, mp 277-278 oC; 1H-NMR (δ, DMSO-d6): 3.22 (1H, dd, J = 5.0, 18.1 Hz, 4-
Htrans), 4.02 (1H, dd, J = 12.5, 18.1 Hz, 4-Hcis), 5.76 (1H, dd, J = 5.0, 12.5 Hz, 5-H), 7.14-8.29 
(m, 13 arom. H), 12.42 (1H, s, COOH); 13C-NMR (δ, DMSO-d6): 42.4, 62.9, 112.5, 120.9, 
123.8, 125.6, 126.7, 127.6, 129.0, 130.7, 138.0, 141.3, 146.1, 146.9, 147.5, 166.9; IR (cm-1): 
1686, 1595, 1552, 1514, 1430, 1339, 1277, 1236, 1174, 1135, 1105, 848, 770, 6.99; Anal. Calcd. 
for C22H17N3O4: C, 68.21; H, 4.42; N, 10.84. Found: C, 68.30; H, 4.38; N, 10.92.  
1-(4-Carboxyphenyl)-5-(4-methylphenyl)-3-phenyl-2-pyrazoline (38). Isolated as white 
needles in 84%, mp 241-242 oC; 1H-NMR (δ, DMSO-d6): 2.22 (3H, s, Me), 3.18 (1H, dd, J = 
5.1, 17.4 Hz, 4-Htrans), 3.98 (1H, dd, J = 11.8, 17.4 Hz, 4-Hcis), 5.60 (1H, dd, J = 5.1, 11.8 Hz, 5-
H), 7.04-7.82 (m, 13 arom. H), 12.10 (1H, s, COOH); 13C-NMR (δ, DMSO-d6): 20.5, 42.9, 62.1, 
111.9, 119.8, 125.5, 125.9, 128.6, 129.5, 130.6, 131.7, 136.6, 138.7, 146.9, 167.1; IR (cm-1): 
1667, 1595, 1522, 1410, 1289, 1175, 1136, 873, 842, 773, 691; Anal. Calcd. for C23H20N2O2: C, 
77.51; H, 5.65; N, 7.85 . Found: C, 77.43; H, 5.60; N, 7.92. 
1-(4-Carboxyphenyl)-5-(4-chlorophenyl)-3-phenyl-2-pyrazoline (39). Prepared as pale yellow 
plates in 81% yield, mp 226-227 oC; 1H-NMR (δ, DMSO-d6): 3.20 (1H, dd, J = 4.9, 17.7 Hz, 4-
Htrans), 3.98 (1H, dd, J = 12.1, 17.7 Hz, 4-Hcis), 5.67 (1H, dd, J = 4.9, 12.1 Hz,      5-H), 7.08-7.80 
(m, 13 arom. H), 12.30 (1H, s, COOH); 13C-NMR (δ, DMSO-d6): 42.6, 61.6, 111.9, 120.0, 
125.9, 127.6, 128.6, 128.9, 129.2, 130.7, 131.6, 132.0, 140.6, 146.7, 149.6, 168.4; IR (cm-1): 
1677, 1600, 1519, 1491, 1401, 1311, 1288, 1176, 1128, 1092, 1014, 824, 770, 691; Anal. Calcd. 
for C22H17ClN2O2: C, 70.12; H, 4.55; N, 7.43. Found: C, 70.20, H, 4.51; N, 7.51. 
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5-(4-Bromophenyl)-1-(4-carboxyphenyl)-3-phenyl-2-pyrazoline (40). Obtained as yellow 
needles in 62% yield, mp 214-215 oC; 1H-NMR (δ, DMSO-d6): 3.20 (1H, dd, J = 5.2, 18.1 Hz, 4-
Htrans), 4.01 (1H, dd, J = 11.9, 18.1 Hz, 4-Hcis), 5.68 (1H, dd, J = 5.2, 11.9 Hz, 5-H), 7.02-7.83 
(m, 13 arom. H), 12.38 (1H, s, COOH); 13C-NMR (δ, DMSO-d6): 42.6, 61.6, 111.8, 119.9, 
120.5, 125.9, 127.9, 128.6, 129.2, 130.7, 131.5, 131.8, 141.0, 146.6, 149.6, 167.0; IR (cm-1): 
1676, 1600, 1520, 1487, 1403, 1287, 1175, 1130, 1095, 1011, 873, 821, 770, 691; Anal. Calcd. 
for C22H17BrN2O2: C, 62.72; H, 4.07; N, 6.65. Found: 62.79; H, 4.11; N, 6.72. 
1-(4-Carboxyphenyl)-5-(4-nitrophenyl)-3-phenyl-2-pyrazoline (41). Isolated as yellow plates 
in 77% yield, mp 269-270 oC; 1H-NMR (δ, DMSO-d6): 3.22 (1H, dd, J = 5.2, 17.9 Hz, 4-Htrans), 
4.04 (1H, dd, J = 12.5, 17.9 Hz, 4-Hcis), 5.82 (1H, dd, J = 5.2, 12.5 Hz, 5-H), 7.04-8.21 (m, 13 
arom. H), 12.30 (1H, s, COOH); 13C-NMR (δ, DMSO-d6): 42.5, 61.6, 111.6, 112.8, 123.7, 124.1, 
126.0, 127.1, 128.2, 128.6, 129.3, 130.7, 146.8, 149.1, 149.7, 166.9; IR (cm-1): 1672, 1598, 1520, 
1400, 1342, 1287, 1257, 1171, 1108, 847, 770, 692; Anal. Calcd. for C22H17N3O4: C, 68.21; H, 
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